Macroaxis: Personalized Investing
Simple Personalized Investing

SP 500   1,666   1.18  Index Moved Down -0.07%
FNMFO FNMFO 096770 KDDIF Housewares Technology Aggressive Banks 
United States GSPC USD ...  |  Investing Toolset


Processing
Processing. Please wait...

SXC Health Revenue

 
 Companies |  Insiders  | Dashboard  
     

Revenue breakdown for SXC Health

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of business and is important item when evaluating financial statements of a company. Revenues from a firm's main business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which given company operates.

SXC Health

Revenue

=

Money Received

-

Discounts and Returns

=
5.59 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can includes product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Compare SXC Health to competition
Based on latest financial disclosure SXC Health Solutions Corp reported 5.59 B of revenue. This is much higher than that of sector, and significantly higher than that of Revenue industry, The Revenue for all stocks is over 1000% lower than the firm.

Filter other Stocks by Revenue

Specify Market Cap
Select Revenue Range
Current Range 
Indicate Industry
Click to run this filter
 Run Equity Filter
Filter Other Equities
  
Follow SXC Health Revenue with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Add To Reader
 
Add SXC Health to your reader
 
    
SXCI United States AMEX
SXC Health Solutions Corp
Benchmark S&P 500
Traded on American Stock Exchange
    
    

Other SXC Health Fundamentals

Return On Equity15.49 %
Return On Asset8.87 %
Profit Margin1.79 %
Operating Margin2.76 %
Current Valuation6.4 B
Shares Outstanding68.9 M
Shares Owned by Insiders14.12 %
Shares Owned by Institutions85.30 %
Number of Shares Shorted5.33 M
Price to Earning59.97 times
Price to Book9.34 times
Price to Sales1.19 times
Revenue5.59 B
Gross Profit309.49 M
EBITDA188.01 M
Net Income99.86 M
Cash and Equivalents272.12 M
Cash per Share3.95 times
Total Debt100 M
Debt to Equity0.14 times
Current Ratio1.46 times
Book Value Per Share10.32 times
Cash Flow from Operations150.1 M
Short Ratio7.20 times
One Year High104.79
One Year Low40.36
Earnings Per Share1.59 times
Price to Earnings To Growth1.50 times
Number of Employees1.43 K
Beta0.39
Market Capitalization6.57 B
Total Asset1.28 B
Retained Earnings264.68 M
Working Capital204.23 M
Current Asset649.32 M
Current Liabilities445.09 M
Z Score42.996
Probability Of Bankruptcy1.00 %


 
Analytics
Risk Adjusted Returns Landscape
Live Efficient Frontier
Market Correlation Analysis
Watchlist Analysis
Financial Content
Portfolio Estimation and Projections
Portfolio Theme Builder
 
 
Research Modules
Equities Backtesting Analysis
Instant Retirement Optimizer
Cross-portfolio RSS and Mobile Access
Company, fund, and ETF Directory
Financial Advisor Directory
Insider and Manager Directory
Wealth Management
 Gadgets, Widgets, and Apps          
  
 
Services And Technology
Frequently Asked Questions
Quick Product Tour
Product Technology Overview
Solution Methodology
Plans and Pricing
 
Free Investor Tools
World Market Correlations
Instant Equity Comparator
Watchlist Analysis
Position Suggestions
Equity Alpha Analysis
 
About Us
About Macroaxis
Contact Us
Product Terms Of Use
Service Privacy Policy
Advertising Opportunities
Content

Thanks for checking out Macroaxis

Tell us what you like and what you don't like. We promise we'll not only listen but write you back

Contact Us
Macroaxis is user-driven community of investors. We appreciate any feedback or comment you can provide. Please fill out our quick survey to help us provide your with a better service and user experience

Fill Out Quick Survey
Most of the functionality on our site is free to use. However we do provide premium service to sophisticated investors. Our premium subscription will give you unprecedented capabilities to optimize your portfolios using robust financial analysis toolkit, fast mean-variance optimization engine, and proven portfolio theory

Go Premium